These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9665001)

  • 21. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow.
    Suzuki H; Patel N; Matthews M; DelRossi AJ; Doolin EJ; Hewitt CW
    J Surg Res; 2000 Apr; 89(2):176-83. PubMed ID: 10729247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.
    Murase N; Ye Q; Nalesnik MA; Demetris AJ; Abu-Elmagd K; Reyes J; Ichikawa N; Okuda T; Fung JJ; Starzl TE
    Transplantation; 2000 Dec; 70(11):1632-41. PubMed ID: 11152226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment.
    Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M
    Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal induction of tolerance to skeletal tissue allografts without immunosuppression.
    Butler PE; Lee WP; van de Water AP; Randolph MA
    Plast Reconstr Surg; 2000 Jun; 105(7):2424-30; discussion 2431-2. PubMed ID: 10845297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adenovirus-mediated CTLA4 immunoglobulin based conditioning for non-myeloablative allogeneic hematopoietic cell transplantation to induce tolerance to hind limb allografts in rats].
    Pan H; Wang L; Zhang XD; Mai HX; Liu D; Liu Y; Guo SZ
    Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):937-40. PubMed ID: 19781252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts.
    Hewitt CW; Ramsamooj R; Patel MP; Yazdi B; Achauer BM; Black KS
    Transplantation; 1990 Nov; 50(5):766-72. PubMed ID: 2238052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats.
    Markus PM; Selvaggi G; Cai X; Fung JJ; Starzl TE
    Cell Transplant; 1993; 2(4):345-53. PubMed ID: 8162277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascularized bone-marrow allotransplantation in rats prolongs the survival of simultaneously grafted alloskin.
    Tsuchida Y; Usui M; Uede T
    J Reconstr Microsurg; 2002 May; 18(4):289-94. PubMed ID: 12022034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
    Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation of kidney graft survival by cyclophosphamide-induced tolerance in rats.
    Eto M; Nishimura Y; Matsuo K; Omoto K; Goto K; Kumuzawa J; Nomoto K
    J Urol; 1995 May; 153(5):1693-6. PubMed ID: 7715012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism.
    Shirwan H; Wang HK; Barwari L; Makowka L; Cramer DV
    Transplantation; 1996 May; 61(9):1382-6. PubMed ID: 8629301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
    Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new method of bone marrow transplantation leads to extension of skin allograft survival.
    Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A
    Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor modification leads to prolonged survival of limb allografts.
    Lee WP; Butler PE; Randolph MA; Yaremchuk MJ
    Plast Reconstr Surg; 2001 Oct; 108(5):1235-41. PubMed ID: 11604625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.